<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39408052</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Impact of the COVID-19 Prioritization Recommendations on Pathological Stages of Urologic Malignancies: A Real-World Analysis at a High-Volume Referral Institution.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5992</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13195992</ELocationID><Abstract><AbstractText><b>Background:</b> In response to the COVID-19 pandemic, the European Association of Urology (EAU) Guidelines defined priority groups to guide the prioritization of surgery for urological malignancies. The objective of this study was to evaluate the impact of the COVID-19 prioritization recommendations on tumor pathological characteristics in a real-world setting at our academic referral institution. <b>Methods:</b> We compared baseline and pathological tumor features of all patients with urological malignancies treated during the pandemic period (2020-2021) versus in the post-pandemic period (2022-2023). Our institution adhered to the international recommendations and prioritized those cases defined as "high-risk". <b>Results:</b> Data from 9196 patients treated for urological malignancies were reviewed and grouped according to period of surgery (4401 in the pandemic period vs. 4785 in the post-pandemic period). The overall number of surgical procedures was comparable for all diseases except for the number of radical prostatectomies (1117 vs. 1405; <i>p</i> = 0.03) and partial nephrectomies (609 vs. 759; <i>p</i> = 0.02), which were significantly lower in the pandemic period. Regarding tumor pathological features, none of the recorded variables were found to differ according to period of surgery, including disease stage, tumor grading, presence of necrosis, lymphovascular invasion, and histological variants. <b>Conclusions:</b> A correct policy of prioritization of oncological pathologies during emergency periods and a centralization of oncological cases in reference centers reduce the possible risk of worsening cancer disease features related to the reorganization of healthcare resources.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grosso</LastName><ForeName>Antonio Andrea</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0001-5973-789X</Identifier><AffiliationInfo><Affiliation>Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, 50141 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campi</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5237-0888</Identifier><AffiliationInfo><Affiliation>Unit of Urological Robotic Surgery and Renal Transplantation, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, 50141 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Maida</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, 50141 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pecoraro</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit of Urological Robotic Surgery and Renal Transplantation, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, 50141 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conte</LastName><ForeName>Francesco Lupo</ForeName><Initials>FL</Initials><Identifier Source="ORCID">0000-0002-4316-9055</Identifier><AffiliationInfo><Affiliation>Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, 50141 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cangemi</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, 50141 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catanzaro</LastName><ForeName>Rossella</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, 50141 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kucuku</LastName><ForeName>Neliana</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, 50141 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doumit</LastName><ForeName>Nassima</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, 50141 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mari</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9070-5706</Identifier><AffiliationInfo><Affiliation>Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, 50141 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masieri</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unit of Urological Robotic Surgery and Renal Transplantation, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, 50141 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serni</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unit of Urological Robotic Surgery and Renal Transplantation, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, 50141 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minervini</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5140-4628</Identifier><AffiliationInfo><Affiliation>Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, 50141 Florence, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">healthcare</Keyword><Keyword MajorTopicYN="N">oncology</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39408052</ArticleId><ArticleId IdType="pmc">PMC11477477</ArticleId><ArticleId IdType="doi">10.3390/jcm13195992</ArticleId><ArticleId IdType="pii">jcm13195992</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Campi R., Tellini R., Grosso A.A., Amparore D., Mari A., Viola L., Cocci A., Polverino P., Checcucci E., Alessio P., et al. Deferring Elective Urologic Surgery During the COVID-19 Pandemic: The Patients’ Perspective. Urology. 2021;147:21–26. doi: 10.1016/j.urology.2020.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urology.2020.09.015</ArticleId><ArticleId IdType="pmc">PMC7513799</ArticleId><ArticleId IdType="pubmed">32979378</ArticleId></ArticleIdList></Reference><Reference><Citation>Amparore D., Campi R., Checcucci E., Piana A., Sica M., Grosso A.A., Presutti M., Barzaghi P., Minervini A., Serni S., et al. Patients’ perspective on the use of telemedicine for outpatient urological visits: Learning from the COVID-19 outbreak. Actas Urol. Esp. 2020;44:637–638. doi: 10.1016/j.acuro.2020.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acuro.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC7359779</ArticleId><ArticleId IdType="pubmed">32843151</ArticleId></ArticleIdList></Reference><Reference><Citation>Naspro R., Da Pozzo L.F. Urology in the time of corona. Nat. Rev. Urol. 2020;17:251–253. doi: 10.1038/s41585-020-0312-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41585-020-0312-1</ArticleId><ArticleId IdType="pmc">PMC7095235</ArticleId><ArticleId IdType="pubmed">32203310</ArticleId></ArticleIdList></Reference><Reference><Citation>Amparore D., Campi R., Checcucci E., Sessa F., Pecoraro A., Minervini A., Fiori C., Ficarra V., Novara G., Serni S., et al. Forecasting the Future of Urology Practice: A Comprehensive Review of the Recommendations by International and European Associations on Priority Procedures During the COVID-19 Pandemic. Eur. Urol. Focus. 2020;6:1032–1048. doi: 10.1016/j.euf.2020.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euf.2020.05.007</ArticleId><ArticleId IdType="pmc">PMC7261455</ArticleId><ArticleId IdType="pubmed">32553544</ArticleId></ArticleIdList></Reference><Reference><Citation>Stensland K.D., Morgan T.M., Moinzadeh A., Lee C.T., Briganti A., Catto J.W., Canes D. Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic. Eur. Urol. 2020;77:663–666. doi: 10.1016/j.eururo.2020.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2020.03.027</ArticleId><ArticleId IdType="pmc">PMC7146681</ArticleId><ArticleId IdType="pubmed">32279903</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribal M.J., Cornford P., Briganti A., Knoll T., Gravas S., Babjuk M., Harding C., Breda A., Bex A., Rassweiler J.J., et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur. Urol. 2020;78:21–28. doi: 10.1016/j.eururo.2020.04.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2020.04.056</ArticleId><ArticleId IdType="pmc">PMC7183974</ArticleId><ArticleId IdType="pubmed">32376137</ArticleId></ArticleIdList></Reference><Reference><Citation>Knuf K.M., Maani C.V., Cummings A.K. Clinical agreement in the American Society of Anesthesiologists physical status classification. Perioper. Med. 2018;7:14. doi: 10.1186/s13741-018-0094-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13741-018-0094-7</ArticleId><ArticleId IdType="pmc">PMC6008948</ArticleId><ArticleId IdType="pubmed">29946447</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H., Li B., Couris C.M., Fushimi K., Graham P., Hider P., Januel J.-M., Sundararajan V. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am. J. Epidemiol. 2011;173:676–682. doi: 10.1093/aje/kwq433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwq433</ArticleId><ArticleId IdType="pubmed">21330339</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin M.B., Greene F.L., Edge S.B., Compton C.C., Gershenwald J.E., Brookland R.K., Meyer L., Gress D.M., Byrd D.R., Winchester D.P. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J. Clin. 2017;67:93–99. doi: 10.3322/caac.21388.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21388</ArticleId><ArticleId IdType="pubmed">28094848</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein J.I., Egevad L., Amin M.B., Delahunt B., Srigley J.R., Humphrey P.A. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am. J. Surg. Pathol. 2016;40:244–252. doi: 10.1097/PAS.0000000000000530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PAS.0000000000000530</ArticleId><ArticleId IdType="pubmed">26492179</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Classification of Tumours Editorial Board  . WHO Classification of Tumours. 5th ed. Volume 8. International Agency for Research on Cancer; Lyon, France: 2022.  [(accessed on 1 August 2024)]. Urinary and male genital tumours. Available online:  https://publications.iarc.fr/610.</Citation></Reference><Reference><Citation>Moch H., Cubilla A.L., Humphrey P.A., Reuter V.E., Ulbright T.M. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours. Eur. Urol. 2016;70:93–105. doi: 10.1016/j.eururo.2016.02.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2016.02.029</ArticleId><ArticleId IdType="pubmed">26935559</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutter M.D., Brookes M., Lee T.J., Rogers P., Sharp L. Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: A National Endoscopy Database Analysis. Gut. 2021;70:537–543. doi: 10.1136/gutjnl-2020-322179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-322179</ArticleId><ArticleId IdType="pubmed">32690602</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob L., Loosen S.H., Kalder M., Luedde T., Roderburg C., Kostev K. Impact of the COVID-19 pandemic on cancer diagnoses in general and specialized practices in Germany. Cancers. 2021;13:408. doi: 10.3390/cancers13030408.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13030408</ArticleId><ArticleId IdType="pmc">PMC7865307</ArticleId><ArticleId IdType="pubmed">33499223</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Vahid S., Eberg M., Milroy S., Milkovich J., Wright F.C., Hunter A., Kalladeen R., Zanchetta C., Wijeysundera H.C., et al. Clearing the surgical backlog caused by COVID-19 in Ontario: A time series modelling study. Can. Med. Assoc. J. 2020;192:E1347–E1356. doi: 10.1503/cmaj.201521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.201521</ArticleId><ArticleId IdType="pmc">PMC7647484</ArticleId><ArticleId IdType="pubmed">32873541</ArticleId></ArticleIdList></Reference><Reference><Citation>Uimonen M., Kuitunen I., Paloneva J., Launonen A.P., Ponkilainen V., Mattila V.M. The impact of the COVID-19 pandemic on waiting times for elective surgery patients: A multicenter study. PLoS ONE. 2021;16:e0253875. doi: 10.1371/journal.pone.0253875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253875</ArticleId><ArticleId IdType="pmc">PMC8259989</ArticleId><ArticleId IdType="pubmed">34228727</ArticleId></ArticleIdList></Reference><Reference><Citation>Oderda M., Soria F., Rosi F., Calleris G., Mazzoli S., Giordano A., Pizzuto G., Marquis A., De Bellis M., Vitiello F., et al. COVID-19 pandemic impact on uro-oncological disease outcomes at an Italian tertiary referral center. World J. Urol. 2021;40:263–269. doi: 10.1007/s00345-021-03842-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-021-03842-y</ArticleId><ArticleId IdType="pmc">PMC8475474</ArticleId><ArticleId IdType="pubmed">34562122</ArticleId></ArticleIdList></Reference><Reference><Citation>Tachibana I., Ferguson E.L., Mahenthiran A., Natarajan J.P., Masterson T.A., Bahler C.D., Sundaram C.P. Delaying Cancer Cases in Urology during COVID-19: Review of the Literature. J. Urol. 2020;204:926–933. doi: 10.1097/JU.0000000000001288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JU.0000000000001288</ArticleId><ArticleId IdType="pubmed">32692934</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan V.W.-S., Tan W.S., Asif A., Ng A., Gbolahan O., Dinneen E., To W., Kadhim H., Premchand M., Burton O., et al. Effects of Delayed Radical Prostatectomy and Active Surveillance on Localised Prostate Cancer—A Systematic Review and Meta-Analysis. Cancers. 2021;13:3274. doi: 10.3390/cancers13133274.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13133274</ArticleId><ArticleId IdType="pmc">PMC8268689</ArticleId><ArticleId IdType="pubmed">34208888</ArticleId></ArticleIdList></Reference><Reference><Citation>Campi R., Amparore D., Capitanio U., Checcucci E., Salonia A., Fiori C., Minervini A., Briganti A., Carini M., Montorsi F., et al. Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres. Eur. Urol. 2020;78:11–15. doi: 10.1016/j.eururo.2020.03.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2020.03.054</ArticleId><ArticleId IdType="pmc">PMC7151319</ArticleId><ArticleId IdType="pubmed">32307215</ArticleId></ArticleIdList></Reference><Reference><Citation>Campi R., Tellini R., Grosso A.A., Pecoraro A., Mari A., Raspollini M.R., Gacci M., Carini M., Serni S., Minervini A. Exploring the Diversity and Predictors of Histopathological Findings Across the European Association of Urology Guidelines Office Rapid Reaction Group Priority Groups for Patients with Renal Tumors: Implications for Individualized Prioritization of Renal Cancer Care. Eur. Urol. Open Sci. 2021;34:5–9. doi: 10.1016/j.euros.2021.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euros.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8567362</ArticleId><ArticleId IdType="pubmed">34761237</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandogdu Z., Collins J., Shaw G., Rohn J., Koves B., Sachdeva A., Ghazi A., Haese A., Mottrie A., Kumar A., et al. Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: An international accelerated consensus statement. BJU Int. 2020;127:729–741. doi: 10.1111/bju.15299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bju.15299</ArticleId><ArticleId IdType="pubmed">33185026</ArticleId></ArticleIdList></Reference><Reference><Citation>Cakir O.O., Castiglione F., Tandogdu Z., Collins J., Alnajjar H.M., Akers C., Albersen M., Alifrangis C., Ayres B., Brouwer O., et al. Management of penile cancer patients during the COVID-19 pandemic: An eUROGEN accelerated Delphi consensus study. Urol. Oncol. Semin. Orig. Investig. 2021;39:197.e9–197.e17. doi: 10.1016/j.urolonc.2020.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urolonc.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC7831701</ArticleId><ArticleId IdType="pubmed">33397593</ArticleId></ArticleIdList></Reference><Reference><Citation>Taheri D., Jahanshahi F., Khajavi A., Kafi F., Pouramini A., Farsani R.M., Alizadeh Y., Akbarzadeh M., Reis L.O., Khatami F., et al. The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade. Clin. Genitourin. Cancer. 2022;21:84–90. doi: 10.1016/j.clgc.2022.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clgc.2022.11.016</ArticleId><ArticleId IdType="pmc">PMC9684093</ArticleId><ArticleId IdType="pubmed">36517394</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamand R., Ploussard G., Roumiguié M., Oderda M., Benamran D., Fiard G., Peltier A., Simone G., Van Damme J., Malavaud B., et al. Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: Results from a large European cohort at the times of COVID-19 pandemic. World J. Urol. 2020;39:1789–1796. doi: 10.1007/s00345-020-03402-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-020-03402-w</ArticleId><ArticleId IdType="pmc">PMC7416303</ArticleId><ArticleId IdType="pubmed">32776243</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>